Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Stockholders' Equity (Deficit)

v3.21.2
Condensed Consolidated Statement of Stockholders' Equity (Deficit) - USD ($)
Common Stock [Member]
Equity Payable [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Loss [Member]
Accumulated Deficit [Member]
Total
Beginning balance, value at Dec. 31, 2019 $ 51,381 $ 100,862 $ 94,781,738 $ 8,780 $ (96,657,106) $ (1,714,345)
Beginning balance, shares at Dec. 31, 2019 51,380,969          
Issuance of common stock for options exercised $ 1,556   1,932,411     $ 1,933,967
Issuance of common stock for options exercised, Shares 1,556,459         15,000
Issuance of common stock for warrants conversion $ 1,360   1,639,448     $ 1,640,808
Issuance of common stock for warrants conversion, Shares 1,359,500          
Issuance of common stock for debt settlement $ 1,114   2,059,354     2,060,468
Issuance of common stock for debt settlement, Shares 1,113,767          
Stock based compensation     773,938     773,938
Foreign currency translation adjustment       (32,226)   (32,226)
Net loss         (2,918,397) (2,918,397)
Ending balance, value at Dec. 31, 2020 $ 55,411 100,862 101,186,889 (23,446) (99,575,503) 1,744,213
Ending balance, shares at Dec. 31, 2020 55,410,695          
Fair value of options issued with related party debt     124,388     124,388
Stock based compensation     751,878     751,878
Foreign currency translation adjustment       (22,391)   (22,391)
Net loss         (4,109,956) (4,109,956)
Ending balance, value at Sep. 30, 2021 $ 55,411 $ 100,862 $ 102,063,155 $ (45,837) $ (103,685,459) $ (1,511,868)
Ending balance, shares at Sep. 30, 2021 55,410,695